Chocolate covered wafers (Bocadin) in plastic packaging sold under the Mi Costenita brand and packaged and distributed by Yoli, Inc.
⚠ Critical Alert — Stop Using Immediately
This product has been flagged with severe risks (undeclared allergen). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2773-2015.
Undeclared Allergens (Milk): Mi Costenita BOCADIN wafer with chocolate contains undeclared milk allergens.
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2773-2015.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Yoli, Inc. Dba Mi Costenita or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2773-2015.
Yoli, Inc. dba Mi Costenita
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
Yoli, Inc. Dba Mi Costenita Recall FAQ
Yoli, Inc. Dba Mi Costenita is the subject of a snacks & candy safety report: Chocolate covered wafers (Bocadin) in plastic packaging sold under the Mi Costenita brand and packaged and distributed by Yoli, Inc.. The notice was published on September 5, 2013 by the U.S. Food and Drug Administration (FDA). Approximately 2,184 units are potentially affected.